Belatacept Kidney Transplant Conversion Study

Investigator: Richard Knight, MD

Study Coordinator: Joel Cisneros

Status: Enrolling

ClinicalTrials.gov Number: NCT01820572

Phone: 713.441.6311

IRB Number: Pro00009063

Description

The primary purpose is to assess the benefits and risks of changing from Cyclosporine or Tacrolimus to Belatacept between 6-36 months after kidney transplant.
More to Explore